Clinical Trial: High Doses of Candesartan Cilexetil on the Reduction of Proteinuria

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Double-Blind, Randomised, Dose Ranging, Multi-Centre, Phase IIIb Study to Evaluate the Efficacy and Safety of High Doses of Candesartan Cilexetil (Atacand®) on the Reduction of

  • To determine the effects of high dose candesartan cilexetil on renal function as measured by serum creatinine and 24-hour creatinine clearance
  • To determine the effects of high dose candesartan cilexetil on blood pressure


    • Original Secondary Outcome:

    • a. To determine the effects of high dose candesartan cilexetil on renal function as measured by serum creatinine and 24-hour creatinine clearance.
    • b. To determine the effects of high dose candesartan cilexetil on blood pressure


    Information By: AstraZeneca

    Dates:
    Date Received: October 18, 2005
    Date Started: April 2003
    Date Completion:
    Last Updated: December 17, 2007
    Last Verified: December 2007